ID: ALA2381474

Max Phase: Preclinical

Molecular Formula: C18H16FN3O

Molecular Weight: 309.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)c1ccc(-n2cc(C(=O)c3ccccc3F)nn2)cc1

Standard InChI:  InChI=1S/C18H16FN3O/c1-12(2)13-7-9-14(10-8-13)22-11-17(20-21-22)18(23)15-5-3-4-6-16(15)19/h3-12H,1-2H3

Standard InChI Key:  IJUMBLTWLNWWER-UHFFFAOYSA-N

Associated Targets(Human)

Estrogen-related receptor alpha 573 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 309.34Molecular Weight (Monoisotopic): 309.1277AlogP: 3.76#Rotatable Bonds: 4
Polar Surface Area: 47.78Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.91CX LogD: 4.91
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.69Np Likeness Score: -1.96

References

1. Xu S, Zhuang X, Pan X, Zhang Z, Duan L, Liu Y, Zhang L, Ren X, Ding K, Ding K..  (2013)  1-Phenyl-4-benzoyl-1H-1,2,3-triazoles as orally bioavailable transcriptional function suppressors of estrogen-related receptor α.,  56  (11): [PMID:23656512] [10.1021/jm4003928]

Source